Icon

DEFENCATH - (3,000 UNITS/3ML (1,000 UNITS/ML);40.5MG/3ML (13.5MG/ML),5,000 UNITS/5ML (1,000 UNITS/ML);67.5MG/5ML (13.5MG/ML) ; Solution)

HEPARIN SODIUM; TAUROLIDINE CORMEDIX
3,000 UNITS/3ML (1,000 UNITS/ML);40.5MG/3ML (13.5MG/ML),5,000 UNITS/5ML (1,000 UNITS/ML);67.5MG/5ML (13.5MG/ML) ; Solution
Less Than $1000 mn
None None
Less Than 5
None
None None
DEFENCATH is a combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant, indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.
Yes
DEFENCATH Patent 1 Patent 2 Patent 3 Patent 4
*** *********
************* ******* ********* ********** *********** *********** *** ************ ********** ***** *** *****, **** *** ******** ** ***** ************** ** ******* ************* ******* ********* ********** *********** *********** *** ************ ********** ***** *** *****, **** *** ******** ** ***** ************** ** ******* ************* ******* ********* ********** *********** *********** *** ************ ********** ***** *** *****, **** *** ******** ** ***** ************** ** ******* ********* ** ***********, ****** ******** *** **********
  1. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.*,***,*** (*** **, ****). **** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ****** *, ****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.